🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.20
-1.10 (-8.27%)
Nov 20, 2026, 1:21 PM CST

GeneReach Biotechnology Statistics

Total Valuation

TPEX:4171 has a market cap or net worth of TWD 693.67 million. The enterprise value is 524.84 million.

Market Cap693.67M
Enterprise Value 524.84M

Important Dates

The next estimated earnings date is Friday, March 26, 2027.

Earnings Date Mar 26, 2027
Ex-Dividend Date n/a

Share Statistics

TPEX:4171 has 56.86 million shares outstanding. The number of shares has decreased by -1.02% in one year.

Current Share Class 56.86M
Shares Outstanding 56.86M
Shares Change (YoY) -1.02%
Shares Change (QoQ) -1.09%
Owned by Insiders (%) 17.29%
Owned by Institutions (%) n/a
Float 38.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.88
PB Ratio 1.24
P/TBV Ratio 1.27
P/FCF Ratio 109.45
P/OCF Ratio 36.53
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 56.04, with an EV/FCF ratio of 82.81.

EV / Earnings n/a
EV / Sales 2.18
EV / EBITDA 56.04
EV / EBIT n/a
EV / FCF 82.81

Financial Position

The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.35.

Current Ratio 2.50
Quick Ratio 2.21
Debt / Equity 0.35
Debt / EBITDA 21.44
Debt / FCF 31.68
Interest Coverage -9.46

Financial Efficiency

Return on equity (ROE) is -4.31% and return on invested capital (ROIC) is -10.03%.

Return on Equity (ROE) -4.31%
Return on Assets (ROA) -2.60%
Return on Invested Capital (ROIC) -10.03%
Return on Capital Employed (ROCE) -6.97%
Weighted Average Cost of Capital (WACC) 5.42%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.28
Inventory Turnover 1.57

Taxes

Income Tax -3.97M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -36.46% in the last 52 weeks. The beta is 0.40, so TPEX:4171's price volatility has been lower than the market average.

Beta (5Y) 0.40
52-Week Price Change -36.46%
50-Day Moving Average 16.33
200-Day Moving Average 17.97
Relative Strength Index (RSI) 16.70
Average Volume (20 Days) 96,231

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:4171 had revenue of TWD 241.13 million and -22.11 million in losses. Loss per share was -0.39.

Revenue241.13M
Gross Profit 178.37M
Operating Income -44.74M
Pretax Income -28.92M
Net Income -22.11M
EBITDA -2.45M
EBIT -44.74M
Loss Per Share -0.39
Full Income Statement

Balance Sheet

The company has 377.77 million in cash and 200.78 million in debt, with a net cash position of 176.99 million or 3.11 per share.

Cash & Cash Equivalents 377.77M
Total Debt 200.78M
Net Cash 176.99M
Net Cash Per Share 3.11
Equity (Book Value) 566.74M
Book Value Per Share 10.00
Working Capital 273.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.99 million and capital expenditures -12.65 million, giving a free cash flow of 6.34 million.

Operating Cash Flow 18.99M
Capital Expenditures -12.65M
Depreciation & Amortization 42.29M
Net Borrowing -21.49M
Free Cash Flow 6.34M
FCF Per Share 0.11
Full Cash Flow Statement

Margins

Gross margin is 73.97%, with operating and profit margins of -18.55% and -9.17%.

Gross Margin 73.97%
Operating Margin -18.55%
Pretax Margin -11.99%
Profit Margin -9.17%
EBITDA Margin -1.02%
EBIT Margin -18.55%
FCF Margin 2.63%

Dividends & Yields

TPEX:4171 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 1.02%
Shareholder Yield 1.02%
Earnings Yield -3.20%
FCF Yield 0.91%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.

Last Split Date Jul 28, 2023
Split Type Forward
Split Ratio 1.25

Scores

TPEX:4171 has an Altman Z-Score of 2.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.77
Piotroski F-Score 5